摘要:
The compounds of formula I may be used in the treatment of psychiatric disorders such as schizophrenia, bipolar disorder, obsessive-compulsive disorder or autism spectrum disorder.
摘要:
The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.
摘要:
The invention provides pyrimidine compounds of general formula (I), which reduce simultaneously the production of nitric oxide (NO) and prostaglandin E2 (PGE2). They have no negative effect on the viability of cells in concentrations decreasing the production of these factors by up to 50%; they are not cytotoxic. Furthermore, a method of preparation of the pyrimidine compounds of general formula (I), carrying 2-formamido group, a pharmaceutical composition comprising the substituted pyrimidine compounds according to the invention, and the use of these compounds for the treatment of inflammatory and cancer diseases are provided.
摘要:
A composition having BACE 1 inhibitory activity containing a compound represented by the general formula (I):
wherein ring A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; E is lower alkylene; X is S, O, or NR 1 ; R 1 is a hydrogen atom or lower alkyl; R 2a , R 2b , R 3a , R 3b , R 4a and R 4b is each independently a hydrogen atom, halogen, or hydroxy etc.; n and m are each independently an integer of 0 to 3; n+m is an integer of 0 to 3; R 5 is a hydrogen atom or substituted lower alkyl; its pharmaceutically acceptable salt, or a solvate thereof.
摘要翻译:具有BACE 1抑制活性的组合物,其含有通式(I)表示的化合物:其中环A为任选取代的碳环基或任选取代的杂环基; E为低级亚烷基; X是S,O或NR 1; R 1是氢原子或低级烷基; R 2a,R 2b,R 3a,R 3b,R 4a和R 4b各自独立地为氢原子,卤素或羟基等; n和m各自独立地为0〜3的整数; n + m为0〜3的整数, R 5是氢原子或取代的低级烷基; 其药学上可接受的盐或其溶剂合物。
摘要:
L'invention a pour objet les composés de formule (I) :
dans laquelle R 1 , R 2 , R 3 , R 4 et R ont les significations indiquées dans la description, leur procédé de préparation, leur application à titre de médicaments ayant une activité antagoniste du récepteur de la vitronectine et les compositions pharmaceutiques les renfermant.
摘要:
New pharmacologically active heterocyclic derivatives as muscarinic receptor blocking agents, useful for the treatment of gastrointestinal disorders of the following formula wherein R is hydrogen atom or C₁₋₉ alkyl optionally substituted by 2 or 3 radicals, which may be identical or different from each other, selected from aryl, cycloalkyl, hydroxy and carboxamide; R₁ may be any group indicated for R, or NHR₄, in which R₄ is hydrogen atom, C₁₋₄ alkyl substituted by -OOCR₅, in which R₅ is methyl substituted by 2 or 3 radicals, which may be identical or different from each other, selected from aryl, cycloalkyl and hydroxy, or a cycloalkyl substituted by another cycloalkyl; R₂ is hydrogen atom, C₁₋₄ alkyl, a radical -OOCR₅, in which R₅ is as hereinbefore defined; R₃ is hydrogen atom or C₁₋₄ alkyl; n is 0, 1 or 2 provided that at least one among R, R₁, R₂ and R₃ is different from hydrogen atom. The tautomers of the compounds of formula (I) and acid addition salts thereof, as well as the processes for their preparation and pharmaceutical compositions containing them are also described
摘要:
The invention concerns novel compounds of the formula I wherein:
X are selected from halogen, nitro, cyano, alkyl, substituted alkyl, hydroxy, alkoxy, substituted alkoxy, alkenyl, alkenyloxy, alkynyl, alkynyloxy, acyloxy, alkoxycarbonyl, alkylthio, alkylsulfinyl, alkylsulfonyl, sulfamoyl, substituted sulfamoyl, alkanoyloxy, benzyloxy, substituted benzyloxy, amino, substituted amino, and the groups formyl and alkanoyl and the oxime, imine and Schiff base derivatives thereof; R' is selected from hydrogen, alkyl, alkenyl, alkynyl, substituted alkyl, alkylsulfonyl, arylsulfonyl, acyl and an inorganic or organic cation; R 2 is selected from alkyl, substituted alkyl, alkenyl, haloalkenyl, alkynyl and haloalkynyl; R 3 is selected from alkyl, fluoroalkyl, alkenyl, alkynyl, and phenyl; R 4 is selected from hydrogen, halogen, alkyl, cyano and alkoxycarbonyl; and n is selected from the integers 1 to 3.
The compounds of the invention show herbicidal properties and plant growth regulating properties and in further embodiments the invention provides processes for the preparation of compounds of formula 1, intermediates useful in the preparation of the compounds of formula I, compositions containing as active ingredient a compound of formula 1, and herbicidal and plant growth regulating processes utilizing compounds of formula I.
摘要:
The compounds of formula I may be used in the treatment of psychiatric disorders such as schizophrenia, bipolar disorder, obsessive-compulsive disorder or autism spectrum disorder.
摘要:
New 2-(pyrazolopyridin-3-yl)pyrimidine derivatives are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy as inhibitors of Janus Kinases (JAK).